Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE: Safety Overview

Metric RIBOCICLIB RIBOFLAVIN 5'-PHOSPHATE
Total FAERS Reports 27,997 249
Deaths Reported 4,501 0
Death Rate 16.1% N/A
Hospitalizations 6,700 3
Average Patient Age 60.2 yrs 31.1 yrs
% Female Patients 99.0% 31.4%
FDA Approval Date Mar 13, 2017 Apr 15, 2016
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route ORAL N/A
Marketing Status Prescription Prescription